Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

Owens, David; Landgraf, Wolfgang; Frier, Brian M.; Zhang, Mei; Home, Philip D.; Meneghini, Luigi; Bolli, Geremia B.

doi:10.1111/dom.13607

Journal article 699 views 134 downloads

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

David Owens

, Wolfgang Landgraf, Brian M. Frier, Mei Zhang, Philip D. Home, Luigi Meneghini, Geremia B. Bolli

Diabetes, Obesity and Metabolism, Volume: 21, Issue: 2, Pages: 321 - 329

Swansea University Author: David Owens

PDF | Version of Record

Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).
Download (853.72KB)

Check full text

DOI (Published version): 10.1111/dom.13607

Published in:	Diabetes, Obesity and Metabolism
ISSN:	14628902
Published:	2019
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa46180
Tags:	Add Tag No Tags, Be the first to tag this record!

first_indexed	2018-12-03T14:27:21Z
last_indexed	2019-01-24T04:59:23Z
id	cronfa46180
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2019-01-22T14:54:00.0839370</datestamp><bib-version>v2</bib-version><id>46180</id><entry>2018-12-03</entry><title>Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-12-03</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>21</volume><journalNumber>2</journalNumber><paginationStart>321</paginationStart><paginationEnd>329</paginationEnd><publisher/><issnPrint>14628902</issnPrint><keywords/><publishedDay>28</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-02-28</publishedDate><doi>10.1111/dom.13607</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2019-01-22T14:54:00.0839370</lastEdited><Created>2018-12-03T08:28:29.8417300</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>1</order></author><author><firstname>Wolfgang</firstname><surname>Landgraf</surname><order>2</order></author><author><firstname>Brian M.</firstname><surname>Frier</surname><order>3</order></author><author><firstname>Mei</firstname><surname>Zhang</surname><order>4</order></author><author><firstname>Philip D.</firstname><surname>Home</surname><order>5</order></author><author><firstname>Luigi</firstname><surname>Meneghini</surname><order>6</order></author><author><firstname>Geremia B.</firstname><surname>Bolli</surname><order>7</order></author></authors><documents><document><filename>0046180-22012019145212.pdf</filename><originalFilename>46180.pdf</originalFilename><uploaded>2019-01-22T14:52:12.3400000</uploaded><type>Output</type><contentLength>871488</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-01-21T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling	2019-01-22T14:54:00.0839370 v2 46180 2018-12-03 Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0% 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2018-12-03 BMS Journal Article Diabetes, Obesity and Metabolism 21 2 321 329 14628902 28 2 2019 2019-02-28 10.1111/dom.13607 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2019-01-22T14:54:00.0839370 2018-12-03T08:28:29.8417300 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine David Owens 0000-0003-1002-1238 1 Wolfgang Landgraf 2 Brian M. Frier 3 Mei Zhang 4 Philip D. Home 5 Luigi Meneghini 6 Geremia B. Bolli 7 0046180-22012019145212.pdf 46180.pdf 2019-01-22T14:52:12.3400000 Output 871488 application/pdf Version of Record true 2019-01-21T00:00:00.0000000 Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC). true eng
title	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
spellingShingle	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0% David Owens
title_short	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
title_full	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
title_fullStr	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
title_full_unstemmed	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
title_sort	Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
author_id_str_mv	2fd4b7c3f82c6d3bd546eff61ff944e9
author_id_fullname_str_mv	2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens
author	David Owens
author2	David Owens Wolfgang Landgraf Brian M. Frier Mei Zhang Philip D. Home Luigi Meneghini Geremia B. Bolli
format	Journal article
container_title	Diabetes, Obesity and Metabolism
container_volume	21
container_issue	2
container_start_page	321
publishDate	2019
institution	Swansea University
issn	14628902
doi_str_mv	10.1111/dom.13607
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	1
active_str	0
published_date	2019-02-28T03:57:56Z
_version_	1763752937333456896
score	11.013731

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

Similar Items